Global Wearable InjectorsMarket is anticipated to
reach USD 11.3 billion by 2025, according to a new report by Grand View
Research, Inc. The market is expected to witness lucrative growth during the
forecast period owing to technological advancements in wearable injectors
coupled with rising demand for round-the-clock monitoring. The paradigm shift
towards self-administration of injectable is expected to drive the market
during the forecast period. In addition, increasing awareness and rising
adoption of wearable injectors are expected to assist in growth.
Technological advancements in wearable injectors, such as
Bluetooth integrated wearable injectors, enable sending alerts to patients,
such as injection reminders, and provide patients access to data regarding
their therapy regime. Also, optional smart functionality provides connectivity
to the healthcare network. Some of these devices have buttons that are
accessible through clothing, and others prevent accidental activation. They
also have audio and visual status indicators or signals. Patients can
self-administer drugs subcutaneously in less time and with minimal effort as
compared to intravenous or other routes. Patients are not required to visit any
healthcare provider for administration.
Prevalence of lifestyle-associated diseases, such as
diabetes and hypertension, is expected to increase during the forecast period.
These diseases demand round-the-clock monitoring of various physiological
parameters, such as blood pressure and blood sugar levels. Thus, integration of
healthcare data with wearable injectors, which gets forwarded to physicians or
doctors giving them real-time access with minimal errors, is expected to boost
the wearable injectors market.
Full Research Report On Global Wearable Injectors Market
Analysis:
http://www.grandviewresearch.com/industry-analysis/wearable-injectors-market
http://www.grandviewresearch.com/industry-analysis/wearable-injectors-market
Further Key Findings From the Study Suggest:
- The
on-body segment held lucrative market share in 2016, owing to growing
preference of patients for adhesive patches that release the drug easily
and can be worn on the skin
- The
motor-driven segment is expected to register the highest growth over the
forecast period owing to increasing demand from hospitals, clinics, retail
chain stores, and pharmacies
- The
oncology segment is expected to gain the largest market share due to
increasing incidence of cancer worldwide
- North
America is expected to dominate the wearable injectors market over the
forecast period due to rising demand for innovative Information Technology
(IT) solutions to streamline workflow and increasing regulatory
requirements to ensure patient safety
- Some
of the key players in wearable injectors market are Becton, Dickinson and
Company; Johnson & Johnson Services, Inc.; F. Hoffmann-La Roche Ltd.;
Unilife Corporation; SteadyMed Therapeutics, Inc.; Amgen, Inc.; Insulet
Corporation; Enable Injections; West Pharmaceutical Services, Inc.; and
CeQur SA.
View more reports of
this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research
has segmented the Global Wearable Injectors Market on the basis of type,
technology, application, end use, and region:
Type Outlook (Revenue, USD Million, 2014 - 2025)
- On-body
- Off-body
Technology Outlook (Revenue, USD Million, 2014 - 2025)
- Spring-based
- Motor-driven
- Rotary
Pump
- Expanding
Battery
- Other
Application Outlook (Revenue, USD Million, 2014 - 2025)
- Oncology
- Infectious
Disease
- Cardiovascular
Disease
- Autoimmune
Disease
- Other
End-use Outlook (Revenue, USD Million, 2014 - 2025)
- Hospital
- Clinic
- Home
Care
- Other
Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- Mexico
- Middle
East and Africa (MEA)
- South
Africa
View Press Release of this research report by Grand View
Research: http://www.grandviewresearch.com/press-release/global-wearable-injectors-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
No comments:
Post a Comment